ArticleClinical pharmacokinetics2024

Patients with Obesity Should be Recognised as a Special Patient Population During Drug Development of Antibacterial and Antifungal Agents; A Call to Action.

K P van Rhee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.